Dynamics of a nosocomial outbreak of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum beta-lactamase

Journal of Clinical Microbiology
F LuzzaroA Toniolo

Abstract

From November 1998 to August 1999, a large outbreak occurred in the general intensive care unit of the Ospedale di Circolo in Varese (Italy), caused by Pseudomonas aeruginosa producing the PER-1 extended-spectrum beta-lactamase. A total of 108 clinical isolates of P. aeruginosa resistant to broad-spectrum cephalosporins were recovered from 18 patients. Epidemic isolates were characterized by synergy between clavulanic acid and ceftazidime, cefepime, and aztreonam. Isoelectric focusing of crude bacterial extracts detected two nitrocefin-positive bands with pI values of 8.0 and 5.3. PCR amplification and characterization of the amplicons by restriction analysis and direct sequencing indicated that the epidemic isolates carried a bla(PER-1) determinant. The outbreak was of clonal origin as shown by pulsed-field gel electrophoresis analysis. This technique also indicated that the epidemic strain was not related to three other PER-1-positive isolates obtained at the same hospital in 1997. Typing by enterobacterial repetitive intergenic consensus-PCR showed that minor genetic variations occurred during the outbreak. The epidemic strain was characterized by a multiple-drug-resistance phenotype that remained unchanged over the outbreak...Continue Reading

References

Jun 1, 1995·Antimicrobial Agents and Chemotherapy·K BushA A Medeiros
Feb 1, 1995·The Journal of Antimicrobial Chemotherapy·F DanelD M Livermore
May 1, 1993·Antimicrobial Agents and Chemotherapy·P NordmannR Labia
Oct 1, 1995·Clinical Microbiology Reviews·D M Livermore
Nov 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J RelloM S Niederman
Apr 9, 1998·The Journal of Antimicrobial Chemotherapy·G BonfiglioG Nicoletti
Aug 26, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R E Hancock
Sep 17, 1998·The Journal of Antimicrobial Chemotherapy·P Nordmann, M Guibert
Jan 9, 1999·Clinical Microbiology Reviews·G McDonnell, A D Russell
May 1, 1999·The Journal of Antimicrobial Chemotherapy·B PanzigM Gründling
May 15, 1999·Journal of Clinical Microbiology·D M Olive, P Bean
Sep 29, 1999·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·E A ArrudaA S Levin
Mar 4, 2000·Journal of Clinical Microbiology·A TsakrisD M Livermore
Jun 1, 2000·Infectious Disease Clinics of North America·L M Bush, C C Johnson
Jun 6, 2000·The Journal of Antimicrobial Chemotherapy·G ClaeysM Vaneechoutte
Jun 7, 2000·American Journal of Infection Control·D J FlournoyC A Gentry
Jul 18, 2000·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A C FluitF J Schmitz
Feb 20, 2002·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·L PoirelP Nordmann
Mar 1, 2002·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Jean-Claude Pechère, Thilo Köhler

❮ Previous
Next ❯

Citations

Aug 10, 2006·Current Genetics·Lisa R Scully, Michael J Bidochka
Aug 9, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Robert A Bonomo, Dora Szabo
Jan 18, 2007·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Marisa CaccamoGianfranco Amicosante
Nov 26, 2009·Antimicrobial Agents and Chemotherapy·Carlos JuanUNKNOWN Spanish Network for Research in Infectious Diseases
Apr 24, 2003·Antimicrobial Agents and Chemotherapy·Dongeun YongAdolf Bauernfeind
Jul 25, 2003·Antimicrobial Agents and Chemotherapy·Gerhard F WeldhagenPatrice Nordmann
May 25, 2004·Antimicrobial Agents and Chemotherapy·Laurent PoirelPatrice Nordmann
May 22, 2007·Applied and Environmental Microbiology·Delphine GirlichPatrice Nordmann
Oct 15, 2005·Clinical Microbiology Reviews·David L Paterson, Robert A Bonomo
Nov 1, 2002·Journal of Clinical Microbiology·Roberta MigliavaccaLaura Pagani
Mar 30, 2002·Journal of Clinical Microbiology·Laura PaganiGian Maria Rossolini
Jun 17, 2009·Journal of Medical Microbiology·Tanya Strateva, Daniel Yordanov
May 11, 2005·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·J C ValdézG Perdigón
Jun 15, 2005·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·H Giamarellou
Jun 15, 2005·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·G M Rossolini, E Mantengoli
Mar 1, 2012·Journal of Veterinary Diagnostic Investigation : Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc·Joanne L AllenGlenn F Browning
Nov 18, 2004·The Journal of Antimicrobial Chemotherapy·Ja-Young KimKyo-Young Lee
Jan 6, 2019·Applied and Environmental Microbiology·Yongqiang YangRodrigo C Bicalho
Jul 20, 2002·Current Opinion in Infectious Diseases·Ian M Gould
Oct 3, 2002·Current Opinion in Critical Care·Robert P Baughman
Apr 20, 2002·Current Opinion in Infectious Diseases·D L Paterson
Jan 15, 2003·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·F LuzzaroUNKNOWN AMCLI Lombardia Hospital Infectious Study Group
Apr 3, 2021·Burns : Journal of the International Society for Burn Injuries·Asma Tchakal-MesbahiLaurence G Rahme
Feb 18, 2005·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Z AktaşP Nordmann

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Beta-lactamase Inhibitors (ASM)

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Beta-lactamase Inhibitors

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.